Home/Filings/4/0001213900-22-000807
4//SEC Filing

Hexter Joshua 4

Accession 0001213900-22-000807

CIK 0001176309other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:33 PM ET

Size

7.3 KB

Accession

0001213900-22-000807

Insider Transaction Report

Form 4
Period: 2022-01-03
Hexter Joshua
COO & CBO
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-03+36,00036,000 total
    Exercise: $13.89Exp: 2032-01-03Common Stock (36,000 underlying)
  • Award

    Common Stock

    2022-01-03+21,000124,333 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 5,250 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]The Stock Option will vest in 4 installments as follows: 9,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.

Documents

1 file

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001573235

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:33 PM ET
Size
7.3 KB